Skip to main content
SpringerLink
Log in

Wie häufig? Wie bekannt? Wie therapiert?

Die Epidemiologie der Hypertonie in Deutschland

Epidemiology of hypertension: Prevalence, Awareness and Treatment

  • FORTBILDUNG . SEMINAR
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Die Hypertonie ist eine Zivilisationskrankheit, das wissen die meisten. Aber wie ist sie genau definiert, wie häufig ist sie in Deutschland und wie ist der gegenwärtige Stand der Therapie? Die folgenden Seiten geben Antworten auf diese Fragen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Kannel WB, Gordon T. Evaluation of cardiovascular risk in the elderly: The Framingham Study. Bull NY Acad Med. 1978;54:573–91

    CAS  Google Scholar 

  2. Scholze J. Isolierte systolische Hypertonie. Ein eigenständiges Krankheitsbild. Herz. 2010;35:568–75

    Article  CAS  PubMed  Google Scholar 

  3. Timio M, Verdecchia P, Venanzi S, Gentili A, Ronconi M, Francucci B, Montanari M, Bichisao E. Age and blood pressure changes. A 20-year follow-up study in nuns in a secluded order. Hypertension. 1988;12:457–61

    Article  CAS  PubMed  Google Scholar 

  4. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287:1003–10

    Article  PubMed  Google Scholar 

  5. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13

    Article  PubMed  Google Scholar 

  6. Lim SS, Vos T, Flaxman AD, Danaei G et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60

    Article  PubMed  PubMed Central  Google Scholar 

  7. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1•25 million people. Lancet. 2014;383:1899–1911

    Article  PubMed  PubMed Central  Google Scholar 

  8. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52

    Article  PubMed  Google Scholar 

  9. Wittchen HU, Glaesmaer H, März W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U, Böhler S, Pittrow D, Ruf G for the DETECT-Study Group. Cardiovascular risk factors in primary care: methods and baseline prevalence rates - the DETECT program. Curr Med Res Opin. 2005;21:619–30

    Article  PubMed  Google Scholar 

  10. Keil U, Liese AD, Hense HW, Filipiak B, Döring A, Stieber J, Löwel H. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg Cohort Study 1984-1992. Eur Heart J. 1998;19:1197–1207

    Article  CAS  PubMed  Google Scholar 

  11. Sundström J, Arima H, Woodward M, Jackson R, Karmali K, Lloyd-Jones D, Baigent C, Emberson J, Rahimi K, MacMahon S, Patel A, Perkovic V, Turnbull F, Neal B. Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384:591–8

    Article  PubMed  Google Scholar 

  12. Löwel H, Meisinger C, Heier M, Hymer H, Alte D, Völzke H. Epidemiologie der arteriellen Hypertonie in Deutschland. Ausgewählte Ergebnisse bevölkerungsrepräsentativer Querschnittstudien. Dtsch Med Wochenschr. 2006;131:2586–91

    Article  PubMed  Google Scholar 

  13. Geller JC, Cassens S, Brosz M, Keil U, Bernarding J, Kropf S, Bierwirth RA, Lippmann-Grob B, Schultheiss HP, Schlüter K, Pels K. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. Eur Heart. 2007;28:3051–58

    Article  CAS  Google Scholar 

  14. Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11. J Hum Hypertens. 2015;29:247–53

    Article  CAS  PubMed  Google Scholar 

  15. Diederichs C, Neuhauser H. Regional variations in hypertension prevalence and management in Germany: results from the German Health Interview and Examination Survey (DEGS1). J Hypertens. 2014;32:1405–13

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Gastroenterologie und Hepatologie, Universitätsklinikum Köln, Kerpener Str. 62, D-50937, Köln, Deutschland

    Hans-Michael Steffen (Arzt für Innere Medizin, Gastroenterologe und Kardiologe, ESH Clinical Hypertension Specialist — DHL-Hypertensiologe Oberarzt)

Authors
  1. Hans-Michael Steffen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Michael Steffen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Steffen, HM. Die Epidemiologie der Hypertonie in Deutschland. MMW - Fortschritte der Medizin 158, 63–70 (2016). https://doi.org/10.1007/s15006-016-8781-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-016-8781-0

Keywords

Search

Navigation